Article Cited by others

RESEARCH

Genetic polymorphisms in DPF3 associated with risk of breast cancer and lymph node metastases

Hoyal Carolyn R, Kammerer Stefan, Roth Richard B, Reneland Richard, Marnellos George, Kiechle Marion, Schwarz-Boeger Ulrike, Griffiths Lyn R, Ebner Florian, Rehbock Joachim, Nelson Matthew R, Braun Andreas

Year : 2005| Volume: 4| Issue : 1 | Page no: 13-13

   This article has been cited by
 
1 Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
Cigall Kadoch,Diana C Hargreaves,Courtney Hodges,Laura Elias,Lena Ho,Jeff Ranish,Gerald R Crabtree
Nature Genetics. 2013; 45(6): 592
[Pubmed]  [Google Scholar] [DOI]
2 The role of TP53 and p21 gene polymorphisms in breast cancer biology in a well specified and characterized German cohort
Florian Ebner, Elisabeth Schremmer-Danninger, Joachim Rehbock
Journal of Cancer Research and Clinical Oncology. 2010; 136(9): 1369
[HTML Full text]  [Google Scholar] [DOI]
3 Hijacking the chromatin remodeling machinery: Impact of SWI/SNF perturbations in cancer
Weissman, B., Knudsen, K.E.
Cancer Research. 2009; 69(21): 8223-8230
[Pubmed]  [Google Scholar]
4 Use of SNPs in cancer predisposition analysis, diagnosis and prognosis: Tools and prospects
Boyd, L.K., Mao, X., Lu, Y.-J.
Expert Opinion on Medical Diagnostics. 2009; 3(3): 313-326
[Pubmed]  [Google Scholar]
5 No evidence of familial correlation in breast cancer metastasis
Alice S. Whittemore, Beth Stearman, Vickie Venne, Jerry Halpern, Anna Felberg, Valerie McGuire, Mary Daly, Saundra S. Buys
Breast Cancer Research and Treatment. 2009; 118(3): 575-581
[Pubmed]  [Google Scholar] [DOI]
6 Evaluating new candidate SNPs as low penetrance risk factors in sporadic breast cancer: A two-stage Spanish case-control study
Vega, A., Salas, A., Milne, R.L., Carracedo, B., Ribas, G., Ruibal, Á., de León, A.C., (...), Carracedo, Á.
Gynecologic Oncology. 2009; 112(1): 210-214
[Pubmed]  [Google Scholar]
7 High-throughput techniques in breast cancer: A clinical perspective
Espinosa, E., Redondo, A., Vara, J.A.F., Zamora, P., Casado, E., Cejas, P., Barón, M.G.
European Journal of Cancer. 2006; 42(5): 598-607
[Pubmed]  [Google Scholar]
8 ERCC4 associated with breast cancer risk: A two-stage case-control study using high-throughput genotyping
Milne, R.L., Ribas, G., González-Neira, A., Fagerholm, R., Salas, A., González, E., Dopazo, J., (...), Benítez, J.
Cancer Research. 2006; 66(19): 9420-9427
[Pubmed]  [Google Scholar]
9 Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: Towards personalized medicine
Anderson, J.E., Hansen, L.L., Mooren, F.C., Post, M., Hug, H., Zuse, A., Los, M.
Drug Resistance Updates. 2006; 9(4-5): 198-210
[Pubmed]  [Google Scholar]
10 High-throughput techniques in breast cancer: A clinical perspective
Enrique Espinosa,Andrés Redondo,Juan Ángel Fresno Vara,Pilar Zamora,Enrique Casado,Paloma Cejas,Manuel González Barón
European Journal of Cancer. 2006; 42(5): 598
[Pubmed]  [Google Scholar] [DOI]
11 Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: Towards personalized medicine
Judy E. Anderson,Lise Lotte Hansen,Frank C. Mooren,Markus Post,Hubert Hug,Anne Zuse,Marek Los
Drug Resistance Updates. 2006; 9(4-5): 198
[Pubmed]  [Google Scholar] [DOI]

 

Read this article